期刊文献+

胃癌淋巴转移相关临床病理因素分析 被引量:4

下载PDF
导出
摘要 目的分析胃癌淋巴转移的相关临床病理因素。方法采用单因素分析和多因素分析方法回顾性分析132例胃癌手术患者的临床病理资料与淋巴结转移的关系。结果 132例胃癌中,共检出淋巴结3 641枚,淋巴结转移率为20.10%(732/3 641);单因素分析发现,患者年龄、肿瘤大小、肿瘤浸润深度、脉管内癌栓、肿瘤细胞分型和癌组织Cerb-B2表达等均与淋巴结转移有关(P<0.05),多因素分析显示,肿瘤浸润深度是影响淋巴结转移的独立因素;T3分期的淋巴结转移率分别高于T2、T1分期(P<0.01),并且,pN3分期中,T3期的淋巴结转移率也明显高于T1、T2期(P<0.01),而其pN2期中淋巴结转移率与T1期相比明显升高(P<0.05)。结论胃癌胃壁浸润深度是影响淋巴结转移的主要因素,术中判断肿瘤是否侵出浆膜可能为选择合理手术方式提供依据。
出处 《广东医学》 CAS CSCD 北大核心 2012年第14期2135-2137,共3页 Guangdong Medical Journal
  • 相关文献

参考文献8

  • 1刘晓文,王亚农,朱蕙燕,徐宇.淋巴结转移阳性比率在预测T_3期胃癌患者预后中的价值[J].中国癌症杂志,2009,19(5):371-376. 被引量:18
  • 2杨永栋,阿不都外力.吾守尔,陈兵,王云海,李涛,文西年.胃癌淋巴结转移规律的研究[J].新疆医科大学学报,2007,30(8):824-826. 被引量:6
  • 3ROVIELLO F, MARRELI D, MORGAGNI P, et al. Benefits of extended lymphadeneetomy in patients with gastric carcinoma with metastasis to second level lymphnodes [ J ]. Chir Ital, 2003, 55 (4) : 491 -498.
  • 4彭开勤.正视胃癌手术规范化[J].腹部外科,2008,21(4):210-211. 被引量:1
  • 5HARTGRINK H H, VAN DE VELDE C J, PUTIER H, et al. Ex- tended lymph node dissection from gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trim [J]. J Clin Oncol, 2004, 22(11) : 2069 -2077.
  • 6王晓娜,倪姗姗,梁寒.淋巴结转移率对胃癌患者预后的影响[J].中华普通外科杂志,2008,23(6):411-415. 被引量:15
  • 7KODERA Y, YAMAMARA Y, KANERN1TSU Y, et al. Lymph node metastasis in cancer of the middle - third stomach: criteria for treatment with a pylorus- preserving gastrectomy [ J ]. Surg Today, 2001, 31 (3) : 196 -203.
  • 8STEVANOVIC D, RADOVANOVIC D, PAVIOVIC I, et al. Effects of systematic lymph adenectomy on length of survival in patients with gastric carcinoma[J]. Med Pregl, 2004, 57(314): 175 -180.

二级参考文献30

  • 1薛英威,陈国林,张豈凡,赵家宏,丁立.胃淋巴回流的动态观察与分析[J].肿瘤防治研究,1995,22(1):1-4. 被引量:9
  • 2李凯,徐惠绵,陈峻青.淋巴结转移率和数量分级与胃癌预后及病理因素关系的研究[J].中华医学杂志,2005,85(30):2113-2116. 被引量:25
  • 3Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratiobased lymph node staging in gastric carcinoma. Ann Surg Oncol, 2002,9:27-34.
  • 4Ichikura T, Ogawa T, Chochi K,et al. Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma. World J Surg, 2003,27: 330-333.
  • 5Kunisaki C, Makino H, Akiyama H, et al. Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg,2008,12,542-549.
  • 6Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol, 2003, 10 : 1077-1085.
  • 7Bando E, Yonemura Y, Taniquchi K, et al. Outcome of ratio lymph node metastasis in gastric carcinoma. Ann Surg Oncol, 2002,9:775-784
  • 8Ikequchi M, Oka S, Gomyo Y, et al. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer. Anticancer Res, 2000,20:1285-1259.
  • 9Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery : morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol, 2004,22:2767-2773.
  • 10Siewert JR,Bittcher K,Stein H J,et al.Relevant prognostic factors in gastric cancer:ten-year results of the German Gastric Cancer Study[J].Ann Surg,1998,228:449-461.

共引文献34

同被引文献30

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部